谷歌浏览器插件
订阅小程序
在清言上使用

Significantly Higher Pathologic Complete Response (pcr) after the Concurrent Use of Trastuzumab and Anthracycline-Based Neoadjuvant Chemotherapy for HER2-positive Breast Cancer: Evidence from a Meta-Analysis of Randomized Controlled Trials.

Journal of Cancer(2018)

引用 12|浏览22
关键词
Breast cancer,Neoadjuvant chemotherapy,Pathologic complete response (pCR),Human epidermal growth factor receptor 2 (HER2),Meta-analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要